ABL Bio (Korea) Odds of Future Stock Price Finishing Over 25381.25

298380 Stock  KRW 24,600  800.00  3.15%   
ABL Bio's future price is the expected price of ABL Bio instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of ABL Bio performance during a given time horizon utilizing its historical volatility. Check out ABL Bio Backtesting, ABL Bio Valuation, ABL Bio Correlation, ABL Bio Hype Analysis, ABL Bio Volatility, ABL Bio History as well as ABL Bio Performance.
  
Please specify ABL Bio's target price for which you would like ABL Bio odds to be computed.

ABL Bio Target Price Odds to finish over 25381.25

The tendency of ABL Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over W 25,381  or more in 90 days
 24,600 90 days 25,381 
about 31.54
Based on a normal probability distribution, the odds of ABL Bio to move over W 25,381  or more in 90 days from now is about 31.54 (This ABL Bio probability density function shows the probability of ABL Stock to fall within a particular range of prices over 90 days) . Probability of ABL Bio price to stay between its current price of W 24,600  and W 25,381  at the end of the 90-day period is about 14.35 .
Assuming the 90 days trading horizon ABL Bio has a beta of 0.42. This suggests as returns on the market go up, ABL Bio average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding ABL Bio will be expected to be much smaller as well. Additionally ABL Bio has an alpha of 0.3037, implying that it can generate a 0.3 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   ABL Bio Price Density   
       Price  

Predictive Modules for ABL Bio

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ABL Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ABL Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
24,59624,60024,604
Details
Intrinsic
Valuation
LowRealHigh
20,67120,67427,060
Details
Naive
Forecast
LowNextHigh
22,81322,81722,821
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
22,25224,65827,064
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as ABL Bio. Your research has to be compared to or analyzed against ABL Bio's peers to derive any actionable benefits. When done correctly, ABL Bio's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in ABL Bio.

ABL Bio Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. ABL Bio is not an exception. The market had few large corrections towards the ABL Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ABL Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ABL Bio within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
0.30
β
Beta against NYSE Composite0.42
σ
Overall volatility
2,070
Ir
Information ratio 0.07

ABL Bio Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ABL Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ABL Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
ABL Bio had very high historical volatility over the last 90 days
The company reported the revenue of 5.33 B. Net Loss for the year was (43.56 B) with profit before overhead, payroll, taxes, and interest of 8.06 B.
ABL Bio has accumulated about 21.59 B in cash with (40.61 B) of positive cash flow from operations.
Roughly 32.0% of the company shares are owned by insiders or employees

ABL Bio Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ABL Stock often depends not only on the future outlook of the current and potential ABL Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ABL Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding47.1 M
Cash And Short Term Investments43.6 B
Shares Float28 M

ABL Bio Technical Analysis

ABL Bio's future price can be derived by breaking down and analyzing its technical indicators over time. ABL Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ABL Bio. In general, you should focus on analyzing ABL Stock price patterns and their correlations with different microeconomic environments and drivers.

ABL Bio Predictive Forecast Models

ABL Bio's time-series forecasting models is one of many ABL Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary ABL Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about ABL Bio

Checking the ongoing alerts about ABL Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for ABL Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
ABL Bio had very high historical volatility over the last 90 days
The company reported the revenue of 5.33 B. Net Loss for the year was (43.56 B) with profit before overhead, payroll, taxes, and interest of 8.06 B.
ABL Bio has accumulated about 21.59 B in cash with (40.61 B) of positive cash flow from operations.
Roughly 32.0% of the company shares are owned by insiders or employees
Check out ABL Bio Backtesting, ABL Bio Valuation, ABL Bio Correlation, ABL Bio Hype Analysis, ABL Bio Volatility, ABL Bio History as well as ABL Bio Performance.
Note that the ABL Bio information on this page should be used as a complementary analysis to other ABL Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Complementary Tools for ABL Stock analysis

When running ABL Bio's price analysis, check to measure ABL Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABL Bio is operating at the current time. Most of ABL Bio's value examination focuses on studying past and present price action to predict the probability of ABL Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABL Bio's price. Additionally, you may evaluate how the addition of ABL Bio to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Please note, there is a significant difference between ABL Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if ABL Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ABL Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.